Ocuphire Pharma, Inc. (Nasdaq:OCUP)
Health Care/Life Sciences • Pharmaceuticals
CIK 1228627
Company
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Address
37000 Grand River Avenue
Suite 120
Farmington Hills, Michigan 48335
37000 Grand River Avenue
Suite 120
Farmington Hills, Michigan 48335
Employees
9
9
Stock Info
Close
$2.4300
$2.4300
Day Range
2.3898 - 2.4740
2.3898 - 2.4740
52 Week Range
2.3400 - 6.6000
2.3400 - 6.6000
Average volume
209.6K
209.6K
Short Interest
1.75M (02/15/24)
1.75M (02/15/24)
% of Float Shorted
7.86%
7.86%
Market Cap
$59.43M
$59.43M
Revenue
$39.85M
$39.85M
Net Income
$17.89M
$17.89M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director George Magrath III, MD |
Director Jay S Pepose MD, PhD |
Chairman Cam S Gallagher MBA |
Lead Independent Director Sean Ainsworth MBA |
Independent Director James S. J Manuso PhD, MBA |
Independent Director Richard J Rodgers MBA, CPA |
Independent Director Susan K Benton MBA |
SEC filings
Date | Form | Event |
---|---|---|
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 4 | |
13 Jun, 2024 | 8-K | |
30 May, 2024 | DEFR14A | |
24 May, 2024 | 4 | |
21 May, 2024 | 4 | |
10 May, 2024 | 8-K | |
10 May, 2024 | 10-Q | |
10 May, 2024 | 8-K | |
29 Apr, 2024 | DEFA14A | |
29 Apr, 2024 | DEF 14A | |
29 Apr, 2024 | ARS | |
19 Apr, 2024 | PRE 14A | |
17 Apr, 2024 | 8-K | |
15 Apr, 2024 | 4 | |
27 Mar, 2024 | 8-K | |
25 Mar, 2024 | 4 | |
25 Mar, 2024 | 4 | |
20 Mar, 2024 | 4 | |
8 Mar, 2024 | 10-K | |
8 Mar, 2024 | 8-K | |
16 Feb, 2024 | 424B3 | |
16 Feb, 2024 | 8-K | |
14 Feb, 2024 | 3 | |
14 Feb, 2024 | 3 | |
14 Feb, 2024 | 4 | |
14 Feb, 2024 | 4 | |
23 Jan, 2024 | EFFECT | |
22 Jan, 2024 | CORRESP | |
22 Jan, 2024 | 4 | |
22 Jan, 2024 | 4 | |
19 Jan, 2024 | UPLOAD | |
12 Jan, 2024 | 4 | |
12 Jan, 2024 | 4 | |
12 Jan, 2024 | 4 | |
11 Jan, 2024 | S-8 | |
10 Jan, 2024 | S-3 | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
3 Jan, 2024 | 4 | |
6 Dec, 2023 | 8-K | |
5 Dec, 2023 | 4 | |
27 Nov, 2023 | 3 | |
27 Nov, 2023 | 4 | |
27 Nov, 2023 | 8-K | |
21 Nov, 2023 | S-8 | |
13 Nov, 2023 | 8-K | |
13 Nov, 2023 | 4 | |
13 Nov, 2023 | 4 | |
13 Nov, 2023 | 10-Q | |
3 Nov, 2023 | 3 | |
3 Nov, 2023 | 4 | |
2 Nov, 2023 | 8-K | |
1 Nov, 2023 | 8-K | CEO Change |
27 Sep, 2023 | 8-K | |
14 Aug, 2023 | 424B5 | |
11 Aug, 2023 | 8-K | |
11 Aug, 2023 | 10-Q | |
1 Aug, 2023 | 8-K | |
12 Jul, 2023 | UPLOAD | |
7 Jul, 2023 | CORRESP | |
28 Jun, 2023 | UPLOAD | |
14 Jun, 2023 | 8-K | |
9 Jun, 2023 | 8-K | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
2 Jun, 2023 | 8-K | |
15 May, 2023 | 8-K | |
15 May, 2023 | 10-Q | |
1 May, 2023 | DEF 14A | |
1 May, 2023 | ARS | |
26 Apr, 2023 | 4 | |
26 Apr, 2023 | 3 | |
21 Apr, 2023 | 4 | |
21 Apr, 2023 | 4 | |
21 Apr, 2023 | 4 | |
21 Apr, 2023 | 4 | |
21 Apr, 2023 | 8-K | CEO Change |
5 Apr, 2023 | S-8 | |
30 Mar, 2023 | 10-K | |
30 Mar, 2023 | 8-K | |
14 Feb, 2023 | 5 | |
14 Feb, 2023 | 5 | |
14 Feb, 2023 | SC 13G/A | |
25 Jan, 2023 | 8-K | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
12 Jan, 2023 | 4 | |
6 Jan, 2023 | 4 | |
6 Dec, 2022 | 8-K | |
7 Nov, 2022 | 8-K | |
4 Nov, 2022 | 10-Q | |
4 Nov, 2022 | 8-K | |
20 Oct, 2022 | 4 | |
14 Oct, 2022 | 8-K | |
12 Oct, 2022 | 4 | |
4 Oct, 2022 | 4 | |
8 Sep, 2022 | 4 | |
12 Aug, 2022 | 10-Q | |
12 Aug, 2022 | 8-K | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
6 Jul, 2022 | 4 | |
17 Jun, 2022 | 8-K | |
15 Jun, 2022 | 4 | |
15 Jun, 2022 | 4 | |
15 Jun, 2022 | 4 | |
15 Jun, 2022 | 4 | |
15 Jun, 2022 | 4 | |
15 Jun, 2022 | 4 | |
10 Jun, 2022 | 8-K | |
10 Jun, 2022 | DEFA14A | |
2 Jun, 2022 | DEFA14A | |
24 May, 2022 | 4 | |
23 May, 2022 | 4 | |
19 May, 2022 | 8-K | |
17 May, 2022 | SC 13G | |
13 May, 2022 | 8-K | |
13 May, 2022 | 10-Q | |
28 Apr, 2022 | 8-K | |
27 Apr, 2022 | DEF 14A | |
27 Apr, 2022 | DEFA14A | |
13 Apr, 2022 | 4 | |
5 Apr, 2022 | 4 | |
5 Apr, 2022 | S-8 | |
5 Apr, 2022 | 4 | |
29 Mar, 2022 | 8-K | |
24 Mar, 2022 | 10-K | |
24 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | 5 | |
1 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
31 Jan, 2022 | 8-K | |
31 Jan, 2022 | 8-K | |
18 Jan, 2022 | SC 13G/A | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
14 Dec, 2021 | 4 | |
22 Nov, 2021 | 4 | |
15 Nov, 2021 | 8-K | |
12 Nov, 2021 | 10-Q | |
4 Oct, 2021 | 4 | |
4 Oct, 2021 | 4 | |
15 Sep, 2021 | 4 | |
3 Sep, 2021 | 4 | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | 10-Q | |
2 Jul, 2021 | 4 | |
2 Jul, 2021 | 4 | |
30 Jun, 2021 | 8-K | |
23 Jun, 2021 | 8-K | |
9 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
9 Jun, 2021 | 3 | |
9 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
8 Jun, 2021 | 8-K | |
7 Jun, 2021 | 8-K/A | |
7 Jun, 2021 | 424B5 | |
4 Jun, 2021 | 8-K | |
7 May, 2021 | 8-K | |
7 May, 2021 | 10-Q | |
26 Apr, 2021 | DEFA14A | |
26 Apr, 2021 | DEF 14A | |
12 Apr, 2021 | 8-K | |
5 Apr, 2021 | 4 | |
5 Apr, 2021 | 4 | |
31 Mar, 2021 | S-8 | |
26 Mar, 2021 | SC 13G | |
17 Mar, 2021 | SC 13G | |
15 Mar, 2021 | 8-K | |
11 Mar, 2021 | 424B5 | |
11 Mar, 2021 | 8-K | |
11 Mar, 2021 | 8-K | |
11 Mar, 2021 | 10-K | |
17 Feb, 2021 | 424B4 | |
16 Feb, 2021 | SC 13G/A | |
12 Feb, 2021 | EFFECT | |
11 Feb, 2021 | CORRESP | |
11 Feb, 2021 | S-3/A | |
10 Feb, 2021 | UPLOAD | |
4 Feb, 2021 | S-3 | |
4 Feb, 2021 | 8-K | |
2 Feb, 2021 | SC 13G/A | |
6 Jan, 2021 | 8-K |
Last update:2024-03-06 12:31:21.809611
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.